Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Drug-Related Side Effects and Adverse Reactions × Taxes × Clear all

Sponsor

Conditions

Breast Neoplasms 47 Fallopian Tube Neoplasms 22 Carcinoma, Non-Small-Cell Lung 21 Ovarian Neoplasms 17 Triple Negative Breast Neoplasms 15 Pancreatic Neoplasms 11 Breast Neoplasms, Male 11 Lung Neoplasms 9 Brenner Tumor 9 Inflammatory Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Melanoma 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Adenocarcinoma Of Esophagus 4 Squamous Cell Carcinoma of Head and Neck 3 Pleural Effusion, Malignant 3 Endometrial Adenocarcinoma 3 Cholangiocarcinoma 3 Adenocarcinoma, Bronchiolo-Alveolar 3 Thymoma 2 Pancreatic Adenocarcinoma 2 Neurotoxicity Syndromes 2 Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Breast Carcinoma In Situ 2 Brain Neoplasms 2

Interventions

Pyridoxine 2 Etoposide 2 Cytarabine 2 Cyclophosphamide 2 sodium thiosulfate 1 pegfilgrastim 1 pegaspargase 1 etoposide phosphate 1 Vincristine 1 Triptorelin Pamoate 1 Rituximab 1 Radiotherapy 1 Prednisolone 1 Methylprednisolone 1 Methotrexate 1 Mercaptopurine 1 Leucovorin 1 Hydrocortisone 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Doxorubicin 1 Dexrazoxane 1 Dexamethasone 1 Carboplatin 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡